Printer Friendly

Walking the Tightrope: Considering the Limiting Factor in the Glycemic Management of Diabetes.

ORLANDO, Fla. -- Does aggressive treatment of Glucose Control in a diabetes patient actually put them at risk? Philip E. Cryer, MD will examine this issue at the American Association of Clinical Endocrinologists' (AACE) 17th Annual Meeting & Clinical Congress, on Saturday, May 17, 2008, at the Walt Disney World Dolphin Resort in Orlando.

"In the battle for glucose control, it's important to recognize that there is a delicate balancing act being performed," Dr. Cryer said. "Failure to respect that could result in recurrent hypoglycemia."

Iatrogenic hypoglycemia results from the treatment of diabetes to achieve a near normal concentration of glucose in the blood. It is known to be the cause of recurrent morbidity in people with both type 1 and advanced type 2 diabetes. It is sometimes fatal.

During his session, Dr. Cryer will examine the mechanisms of Iatrogenic Hypoglycemia and examine ways to minimize the patient's risk.

"Glycemic control can help reduce a patient's risk of a cardiac event or a stroke," Dr. Cryer said. "Provided that it's done safely over time."

At the 2008 AACE Annual Meeting, the correlation between cardiovascular events and diabetes will be taking center stage. A special symposium titled "Clinical Trials Targeting Glycemia: What Do We Expect to Learn?" will consider the impact of glucose control through studies including ACCORD, ADVANCE, VADT, and others. Other sessions of interest include "Insulin Resistance and Atherosclerosis: The Missing Link," and "Diabetes: A Cardiac Condition."

Media Registration:

About AACE:

About the AACE Annual Meeting:

Other AACE Annual Meeting News:
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 15, 2008
Previous Article:Beaumont Hospitals Launches Invention Creation Center.
Next Article:Deutsche Bank to Issue Four Exchange-Traded Notes Linked to the Deutsche Bank Liquid Commodity Index - Optimum Yield Agriculture(TM).

Related Articles
Change in guidelines for glycemic control.
Operation regulation: nutraceutical ingredients for healthy blood sugar; Diabetes continues to sweep populations all around the world, bringing with...

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters